Changes

Jump to: navigation, search

Alopecia - Hair Loss

74 bytes added, 12:58, 25 July 2006
/* GSK-3 Inhibition */
== GSK-3 Inhibition==
* ''GSK-3 inhibition targets treatment of chemotherapy-induced alopecia''
* In the canonical Wnt signaling cascade, adenomatous polyposis coli (APC), axin, and GSK3 constitute the so-called destruction complex, which controls the stability of beta-catenin. It is generally believed that four conserved Ser/Thr residues in the N terminus of beta-catenin are the pivotal targets for the constitutively active serine kinase GSK3. GSK3 covalently modifies beta-catenin by attaching phosphate groups (from ATP) to serine, and threonine residues. In so doing, the functional properties of the protein kinase’s substrate (beta-catenin) are modified.
Anonymous user